Bioceltix SA engages in the research and development in the area of veterinary medicine. It develops stem cell therapy for animal use. The company was founded on August 13, 2018 and is headquartered in Wroclaw, Poland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company